Lidocaine
SIGMA/L1026 - analytical standard
Synonym: 2-Diethylamino-N-
CAS Number: 137-58-6
Empirical Formula (Hill Notation): C14H22N2O
Molecular Weight: 234.34
EC Number: 205-302-8
MDL Number: MFCD00026733
Linear Formula: C14H22N2O
Product Type: Chemical
| application(s) | forensics and toxicology pharmaceutical (small molecule) |
| form | solid |
| grade | analytical standard |
| impurities | ≤0.5% Total Organic Impurities (Lidocaine related compound H ≤0.10% 2,6-Dimethylaniline ≤0.01% Any unspecified impurity ≤0.10% Total impurities ≤0.5%) |
| InChI | 1S/C14H22N2O/c1-5-16(6-2) |
| InChI key | NNJVILVZKWQKPM-UHFFFAOYSA |
| packaging | vial of 200 mg |
| Quality Level | 200 ![]() |
| SMILES string | CCN(CC)CC(=O)Nc1c(C)cccc1 |
| technique(s) | gas chromatography (GC): suitable |
| HPLC: suitable |
| Application: | Lidocaine has been used to examine its effects in inhibiting lymph flow and protection against envenomation. It has also been used to assess its efficacy as an anti-tussive agent. |
| Biochem/physiol Actions: | Na+ channel blocker; class IB antiarrhythmic that is rapidly absorbed after parenteral administration. |
| Biochem/physiol Actions: | Na+ channel blocker; class IB antiarrhythmic. |
| General description: | Lidocaine is an amide anesthetic, which is used to treat ventricular arrhythmias. It lowers cardiac automaticity and myocardial conduction. Lidocaine inhibits the generation and conduction of nerve impulses. It has an anticonvulsant effect. |
| Packaging: | 1 vial in poly bottle |
| Packaging: | Supplied in amber screw-cap vials |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| Safety Statements | 22-26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| UNSPSC | 12352200 |


